Homespace

space

biotech

Base to Base biotech podcast 56: GRIN genes and relapsing MS

Jim Cornall - April 24, 2026

biotech

Positive first-in-human data for IVF-related embryo implantation failure treatment

Jim Cornall - April 23, 2026

biotech

New company plans to replace daily injections with implant

Jim Cornall - April 23, 2026

biotech

UCB adds epilepsy drug through Neurona Therapeutics acquisition

Jim Cornall - April 23, 2026

space

Inauguration of the European Space Deep-Tech Innovation Centre (ESDI)

Jim Cornall - June 3, 2025

space

Simpliforge creates world’s highest on-site 3D printed structure in the Himalayas

Jim Cornall - April 22, 2025

space

SNAP decision to establish University of Glasgow as cutting-edge nano-analysis hub

Jim Cornall - April 7, 2025

space

Funding for Australian aerospace company

Jim Cornall - April 3, 2025

space

Cryogenic fuel management in space

Jim Cornall - March 6, 2025

energy

KAIST develops performance prediction model to boost space electric propulsion technology

Jim Cornall - February 7, 2025

energy

Collecting in-space solar energy

Jim Cornall - October 10, 2024

biotech

LinkGevity secures place in SPACE-H accelerator programme

Jim Cornall - September 30, 2024

12 Page 1 of 2

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Base to Base biotech podcast 56: GRIN genes and relapsing MS

Jim Cornall - April 24, 2026 0

This week, our conversations are with Bruce Leuchter, co-founder, president, CEO of Neurvati Neurosciences and GRIN Therapeutics; and Daniel Vitt, CEO of Immunic. Base to...

Positive first-in-human data for IVF-related embryo implantation failure treatment

biotech Jim Cornall - April 23, 2026 0

New company plans to replace daily injections with implant

biotech Jim Cornall - April 23, 2026 0

UCB adds epilepsy drug through Neurona Therapeutics acquisition

biotech Jim Cornall - April 23, 2026 0

Mechanism ‘opens new era’ for targeted cancer therapy

biotech Jim Cornall - April 22, 2026 0